Search

everythinglearnresearchcommunity

for

Search:↓

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Type I interferons play a key role in the development of various skin diseases.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

No cure exists for alopecia areata, and treatments are personalized.

New treatments focusing on immune pathways show promise for stubborn hair loss.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Fibroblasts are important in healing diabetic wounds, but high sugar levels can harm their function and slow down the healing process.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

CD4+ skin cells may be precursors to basal cell carcinoma.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Testosterone's effects on COVID-19 are unclear and need more research.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.